Close Menu

Cannabinoid Hyperemesis Syndrome in an East Indian: The Case for Genetic Susceptibility

Issue: 
DOI: 
10.7727/wimj.2017.229
Pages: 
581-2

The Editor,

Sir,

Following the first description of Cannabinoid Hyperemesis Syndrome (CHS) in 2004, there have been hundreds of cases reported, up to recently. One of the largest series was at the Mayo Clinic (a non-profit organization in the United States of America) where five African-American patients, three Hispanics and 12 patients of ‘Other’ ethnicities were noted in a series of 98 cases of predominantly Caucasian patients (1, 2).

Accepted: 
27 Oct, 2017
Revised: 
27 Oct, 2017
PDF Attachment: 
e-Published: 19 Dec, 2017
Top of Page